The results of two different antifibrinolytic therapeutic modalities (A = AMCA 3gm daily + Aprotinin, 3-400000 K.I.U daily, B=AMCA, 6 gm daily) were compared retrospectively in a series of 137 patients harbouring recently ruptured intracranial aneurysms. The rates for rebleeding and thromboembolic complications were similar in both differently treated groups of patients, whilst that for ischaemic complications was significantly (p<0.025) lower in cases managed with modality A. In these also the incidence of hydrocephalus was decreased, although not significantly (0.20>p >0.19). According to these data, low-dose AMCA + Aprotinin seems to be a rational therapeutic combination for cases of ruptured intracranial aneurysms, in which antifibrinolytics are indicated
Spallone, A. (1982). Antifibrinolyticsin aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy. ACTA NEUROCHIRURGICA, 63(1-4), 245-250 [10.1007/BF01728878].
Antifibrinolyticsin aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy
SPALLONE, ALDO
1982-03-01
Abstract
The results of two different antifibrinolytic therapeutic modalities (A = AMCA 3gm daily + Aprotinin, 3-400000 K.I.U daily, B=AMCA, 6 gm daily) were compared retrospectively in a series of 137 patients harbouring recently ruptured intracranial aneurysms. The rates for rebleeding and thromboembolic complications were similar in both differently treated groups of patients, whilst that for ischaemic complications was significantly (p<0.025) lower in cases managed with modality A. In these also the incidence of hydrocephalus was decreased, although not significantly (0.20>p >0.19). According to these data, low-dose AMCA + Aprotinin seems to be a rational therapeutic combination for cases of ruptured intracranial aneurysms, in which antifibrinolytics are indicatedI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.